Navigate Up

Women's Center - A-Z Index

#
Y

Print This Page

Chronic myelogenous leukemia (CML)

Chronic myelogenous leukemia (CML) is cancer that starts inside bone marrow. This is the soft tissue in the center of bones that helps form all blood cells.

CML causes an uncontrolled growth of immature cells that make a certain type of white blood cell called myeloid cells. The diseased cells build up in the bone marrow and blood.

Alternative Names

CML; Chronic myeloid leukemia; Chronic granulocytic leukemia; Leukemia - chronic granulocytic

Causes, incidence, and risk factors

Cause of CML is often related to an abnormal chromosome called the Philadelphia chromosome.

Radiation exposure can increase the risk of developing CML. Radiation exposure can be from radiation treatments used in the past to treat thyroid cancer or Hodgkin lymphoma or from a nuclear disaster.

It takes many years to develop leukemia from radiation exposure. Most people treated for cancer with radiation do not develop leukemia. Most patients with CML have not been exposed to radiation.

CML most often occurs in middle-age adults and in children.

Symptoms

Chronic myelogenous leukemia is grouped into several phases:

  • Chronic
  • Accelerated
  • Blast crisis

The chronic phase can last for months or years. The disease may have few or no symptoms during this time. Most people are diagnosed during this stage, when they have blood tests done for other reasons.

The accelerated phase is the more dangerous phase. Leukemia cells grow more quickly. Common symptoms include fever (without infection), bone pain , and a swollen spleen .

Untreated CML leads to the blast crisis phase. Bleeding and infection may occur due to bone marrow failure.

Other possible symptoms of a blast crisis include:

Signs and tests

A physical examination often reveals a swollen spleen. A complete blood count (CBC ) shows an increased number of white blood cells.

Other tests include:

Treatment

Medicine called imatinib (Gleevec) is the first treatment for nearly everyone with CML. Gleevec is a pill, taken by mouth. It targets the abnormal protein made by the Philadelphia chromosome. Other medicines similar to Gleevec may be used.

Sometimes chemotherapy is used to reduce the white blood cell count if it is very high at diagnosis.

The blast crisis phase is very difficult to treat. This is because there is a very high count of immature white blood cells (leukemia cells).

The only known cure for CML is a bone marrow transplant , or stem cell transplant. Most patients, though, do not need a transplant because medicines, such as Gleevec, are successful in treating CML. Discuss your options with your oncologist.

You and your healthcare provider may need to manage many other issues or concerns during your leukemia treatment, including:

Support Groups

You can ease the stress of illness by joining a cancer support group . Sharing with others who have common experiences and problems can help you not feel alone.

Expectations (prognosis)

Taking Gleevec improves the outlook for patients with CML. When the signs and symptoms of CML go away and blood counts and bone marrow biopsy appear normal, the person is considered in remission. Many persons can remain in remission for many years while on this medicine.

Stem cell tansplant is usually considered in persons whose disease comes back after taking Gleevec.

Complications

Blast crisis can lead to complications, including infection, bleeding, fatigue, unexplained fever, and kidney problems. Chemotherapy can have serious side effects, depending on the drugs used.

Prevention

Avoid exposure to radiation when possible.

References

Kantarjian H, Cortes J. Chronic myeloid leukemia. In: Abeloff MD, Armitage JO, Niederhuber JE, et al., eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, PA: Elsevier Churchill-Livingstone; 2008:chap 107

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Chronic Myelogenous Leukemia. Version 4.2013. Available at http://www.nccn.org/professionals/physician_gls/pdf/cml.pdf. Accessed March 7, 2013.

Updated: 3/4/2013

Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by A.D.A.M. Health Solutions, Ebix, Inc., Editorial Team: David Zieve, MD, MHA, Bethanne Blackman, Stephanie Slon, and Nissi Wang.


©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com